Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.

Paul W. Armstrong,Burkert Pieske,Kevin J. Anstrom,Justin A. Ezekowitz,Adrian F. Hernandez,Javed Butler,Lam Csp,Piotr Ponikowski,A. A. Voors,Gang Jia,Steven McNulty,Mahesh J. Patel,Lothar Roessig,Joerg Koglin,Christopher M. O'Connor

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.

2020

Paul W. Armstrong
Burkert Pieske
Kevin J. Anstrom
Justin A. Ezekowitz
Adrian F. Hernandez
Javed Butler
Lam Csp
Piotr Ponikowski
A. A. Voors
Gang Jia
Steven McNulty
Mahesh J. Patel
Lothar Roessig
Joerg Koglin
Christopher M. O'Connor

Abstract Background The effect of vericiguat, a novel oral soluble guanylate cyclase stimulator, in patients with heart failure and reduced ejection fraction who had recently been hospitalized or h...

Keywords:

Diabetes mellitus
Soluble Guanylate Cyclase Stimulator
Medicine
Cardiology
Ejection fraction
Vericiguat
Surgery
Internal medicine
Heart failure
Stroke volume
follow up studies
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

256

Citations